Supermodel Linda Evangelista has navigated a challenging path over the past decade, balancing a public return to the fashion industry with a private journey through significant health obstacles. Known for her iconic 1990s career and a signature short haircut that set global trends, Evangelista has recently addressed personal battles, including a diagnosis of breast cancer and the physical complications stemming from a cosmetic procedure known as CoolSculpting.
In a 2023 interview with The Wall Street Journal, Evangelista disclosed that she had been diagnosed with breast cancer twice in five years. The first diagnosis occurred in 2018, followed by a recurrence in 2022. She described undergoing a bilateral mastectomy as part of her treatment, emphasizing a perspective on recovery that prioritizes long-term health over traditional aesthetic standards. This openness regarding her medical history follows her 2021 decision to speak publicly about the adverse effects of a fat-reduction procedure, which she alleged left her permanently disfigured and led to a legal settlement with the procedure’s parent company, Zeltiq Aesthetics, in 2022, as reported by The New York Times.
The Impact of Cosmetic Complications
Evangelista’s public disclosure regarding CoolSculpting—a non-invasive fat-reduction treatment—brought international attention to a rare side effect known as Paradoxical Adipose Hyperplasia (PAH). According to the American Society of Plastic Surgeons, PAH is a recognized, albeit uncommon, complication where the treated area increases in volume rather than decreasing. Evangelista stated that the procedure, which she underwent between 2015 and 2016, resulted in the growth of hard, painful masses on her body.
In her initial 2021 social media announcement, she described the experience as a period of isolation, noting that the physical changes led her to withdraw from public life for several years. The subsequent legal action concluded in July 2022, with both parties announcing that the case had been resolved. While the financial terms of the settlement remain confidential, the resolution allowed the model to begin a process of professional and personal reconciliation with her appearance.
Health Advocacy and Career Resurgence
The model’s return to the public eye has been marked by a shift in how she approaches the fashion industry. After stepping away from the spotlight for nearly six years, Evangelista participated in a Fendi runway show in 2022 and appeared on the cover of Vogue, where she addressed the physical reality of her post-procedure body. Her willingness to discuss both the PAH diagnosis and her cancer treatments has positioned her as an advocate for body transparency and patient agency.
Medical experts note that Evangelista’s case has increased public awareness of the risks associated with elective cosmetic procedures. By sharing her diagnostic journey, she has highlighted the importance of informed consent and the potential for long-term side effects in non-surgical interventions. Her current focus remains on maintaining her health and continuing her long-standing relationship with the fashion industry, now on her own terms.
Current Status and Future Outlooks
As of late 2023 and into 2024, Evangelista has expressed a commitment to prioritizing her recovery and well-being. She continues to attend medical screenings and maintains a professional schedule that balances her history as a supermodel with her current life as a public advocate. There are no pending public legal actions related to her previous cosmetic claims.
Readers interested in updates regarding cosmetic safety and the official guidelines for procedures like cryolipolysis can consult the American Society of Plastic Surgeons for verified patient resources and safety disclosures. For ongoing health advocacy, official statements from the model are typically shared through her verified social media channels.
Have you found this information helpful? Share your thoughts or questions in the comments section below.
Related reading